spinal muscular atrophy type 3

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:muscular_dystrophy
gptkbp:affects motor neurons
gptkbp:caused_by gptkb:SMN1_gene_mutation
gptkbp:clinical_trial difficulty swallowing
respiratory issues
hypotonia
twitching muscles
proximal muscle weakness
gptkbp:condition gptkb:spinal_muscular_atrophy_type_2
gptkb:spinal_muscular_atrophy_type_1
spinal muscular atrophy type 4
gptkbp:diagnosis variable
genetic testing
family history
clinical evaluation
neurological examination
gptkbp:epidemiology 1 in 10,000 births
more common in certain populations
gptkbp:genetic_studies recommended for families
SMN2 gene copy number
SMN1 gene analysis
https://www.w3.org/2000/01/rdf-schema#label spinal muscular atrophy type 3
gptkbp:inherits_from autosomal recessive
gptkbp:is_affected_by gptkb:children
adults
gptkbp:is_involved_in gptkb:Cure_SMA
gptkb:SMA_Foundation
SMA Support UK
gptkbp:lifespan normal to near normal
gptkbp:premiered_on childhood
gptkbp:public_awareness advocacy for research funding
important for early diagnosis
gptkbp:research gptkb:gene_therapy
clinical trials
gptkbp:research_institutes gptkb:Cure_SMA
gptkb:MDA
gptkb:NIH
gptkbp:symptoms fatigue
difficulty walking
muscle weakness
tremors
muscle wasting
scoliosis
joint contractures
gptkbp:treatment gptkb:risdiplam
gptkb:Zolgensma
gptkb:nusinersen
medications
physical therapy
supportive care
gptkbp:bfsParent gptkb:Nusinersen
gptkbp:bfsLayer 5